Thibaut Mongon, incoming CEO of J&J's spin-off consumer health company
May 11, 2022 12:47 PM EDT
People
Pharma

J&J taps a long­time vet to run its con­sumer health spin­off ahead of next year's sep­a­ra­tion

Tyler Patchen

News Reporter

J&J is turn­ing to long­time in­sid­ers in the ex­ec­u­tive ranks to head up its con­sumer di­vi­sion, once the com­pa­ny com­pletes its spin­out: Thibaut Mon­gon, who …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times